Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13153973
[patent_doc_number] => 10093698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same
[patent_app_type] => utility
[patent_app_number] => 15/307587
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4946
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307587
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307587 | Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same | Nov 20, 2014 | Issued |
Array
(
[id] => 11099634
[patent_doc_number] => 20160296604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'Peptide Having Angiogenesis Inhibitory Activity and Composition Containing Same'
[patent_app_type] => utility
[patent_app_number] => 15/038269
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 10802
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038269
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038269 | Peptide having angiogenesis inhibitory activity and composition containing same | Nov 20, 2014 | Issued |
Array
(
[id] => 11092301
[patent_doc_number] => 20160289269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'NOVEL CELL-PENETRATING COMPOSITIONS AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/036849
[patent_app_country] => US
[patent_app_date] => 2014-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18006
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036849 | Cell-penetrating compositions and methods using same | Nov 19, 2014 | Issued |
Array
(
[id] => 11067658
[patent_doc_number] => 20160264623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'TETRAPEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/031135
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7281
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031135 | Tetrapeptide compound and method for producing same | Oct 22, 2014 | Issued |
Array
(
[id] => 12428244
[patent_doc_number] => 09975922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Peptide inhibitor of HIV reverse transcription
[patent_app_type] => utility
[patent_app_number] => 15/030739
[patent_app_country] => US
[patent_app_date] => 2014-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 52
[patent_no_of_words] => 18577
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/030739 | Peptide inhibitor of HIV reverse transcription | Oct 20, 2014 | Issued |
Array
(
[id] => 11040163
[patent_doc_number] => 20160237119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'C-Met Protein Agonist'
[patent_app_type] => utility
[patent_app_number] => 15/025239
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12642
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025239 | c-Met protein agonist | Oct 14, 2014 | Issued |
Array
(
[id] => 11099621
[patent_doc_number] => 20160296591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF BDNF-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/028592
[patent_app_country] => US
[patent_app_date] => 2014-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23267
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/028592 | COMPOSITIONS AND METHODS FOR TREATMENT OF BDNF-RELATED CONDITIONS | Sep 30, 2014 | Abandoned |
Array
(
[id] => 9839771
[patent_doc_number] => 20150031853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'METHOD FOR THE SELECTIVE ENRICHMENT AND LABELING OF PHOSPHORPROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/501764
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9545
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14501764
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/501764 | Method for the selective enrichment and labeling of phosphorproteins | Sep 29, 2014 | Issued |
Array
(
[id] => 10220341
[patent_doc_number] => 20150105334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'PEPTIDES DERIVED FROM NKP44'
[patent_app_type] => utility
[patent_app_number] => 14/492713
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15270
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492713
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/492713 | Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44 | Sep 21, 2014 | Issued |
Array
(
[id] => 11066231
[patent_doc_number] => 20160263195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROTECTING THE KIDNEY FROM ISCHEMIA REPERFUSION INJURY'
[patent_app_type] => utility
[patent_app_number] => 15/026574
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 32217
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026574 | Compositions and methods for protecting the kidney from ischemia reperfusion injury | Sep 21, 2014 | Issued |
Array
(
[id] => 11486169
[patent_doc_number] => 09592231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-14
[patent_title] => 'Therapy for complications of diabetes'
[patent_app_type] => utility
[patent_app_number] => 14/491479
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16283
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491479
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/491479 | Therapy for complications of diabetes | Sep 18, 2014 | Issued |
Array
(
[id] => 9932097
[patent_doc_number] => 20150080288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'NITRATION SHIELDING PEPTIDES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/486317
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 42372
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486317 | Nitration shielding peptides and methods of use thereof | Sep 14, 2014 | Issued |
Array
(
[id] => 11561714
[patent_doc_number] => 09624286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Composition comprising peptide derived from adiponectin'
[patent_app_type] => utility
[patent_app_number] => 15/022093
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3997
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022093
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022093 | Composition comprising peptide derived from adiponectin | Sep 11, 2014 | Issued |
Array
(
[id] => 12016930
[patent_doc_number] => 09809622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Tumor-targeting polypeptide and application thereof'
[patent_app_type] => utility
[patent_app_number] => 15/021366
[patent_app_country] => US
[patent_app_date] => 2014-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4204
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021366
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/021366 | Tumor-targeting polypeptide and application thereof | Sep 4, 2014 | Issued |
Array
(
[id] => 10279984
[patent_doc_number] => 20150164981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'COMPOSITION AND METHOD FOR INHIBITING, PREVENTING, OR AMELIORATING COMPLICATIONS ASSOCIATED WITH INGESTION OF A MEDICINAL, CHEMICAL, OR BIOLOGICAL SUBSTANCE OR AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/463457
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13887
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14463457
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/463457 | COMPOSITION AND METHOD FOR INHIBITING, PREVENTING, OR AMELIORATING COMPLICATIONS ASSOCIATED WITH INGESTION OF A MEDICINAL, CHEMICAL, OR BIOLOGICAL SUBSTANCE OR AGENT | Aug 18, 2014 | Abandoned |
Array
(
[id] => 12198568
[patent_doc_number] => 09901617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl'
[patent_app_type] => utility
[patent_app_number] => 14/911939
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 67
[patent_no_of_words] => 7647
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911939 | Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl | Aug 13, 2014 | Issued |
Array
(
[id] => 9812116
[patent_doc_number] => 20150024061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'ALLOPLASTIC INJECTABLE DERMAL FILLER AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/449214
[patent_app_country] => US
[patent_app_date] => 2014-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9551
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14449214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/449214 | ALLOPLASTIC INJECTABLE DERMAL FILLER AND METHODS OF USE THEREOF | Jul 31, 2014 | Abandoned |
Array
(
[id] => 10812214
[patent_doc_number] => 20160158374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'CELL-PENETRATING PEPTIDE AND CONJUGATE COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/903827
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9439
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903827
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/903827 | Cell-penetrating peptide and conjugate comprising same | Jul 10, 2014 | Issued |
Array
(
[id] => 10628709
[patent_doc_number] => 09346854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Anti-inflammatory peptides and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/323408
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 15913
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323408 | Anti-inflammatory peptides and use thereof | Jul 2, 2014 | Issued |
Array
(
[id] => 10912769
[patent_doc_number] => 20140315787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'Antioxidant, Anti-Inflammatory, Anti-Radiation, Metal Chelating Compounds And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/323576
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16609
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323576 | Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof | Jul 2, 2014 | Issued |